LIAN Group Acquires Scientis to Expand Healthcare Platform

August 28, 2024

LIAN Group, an owner-operator investment firm, has acquired Scientis, a Swiss dermatology and cosmeceutical company known for its Cyspera pigment-correcting product line. The deal expands LIAN's Healthcare investment platform and aims to accelerate Scientis’ global growth, product development and market penetration across Asia, the United States and other markets.

Buyers
LIAN Group
Targets
Scientis
Platforms
LIAN Group Healthcare platform
Location
Geneva, Switzerland
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.